Close Advertisement Close We need your help now Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough. If you\'ve seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it. €2 a Month €5 a Month One-off amount I already contribute Close * Irish News * FactCheck * Voices * Investigates * J-TV Support Us Sign out | Sign in sections Voices FactCheck Investigates Quizzes Money Diaries Explainers Daft.ie Property Magazine The Journal TV topics Irish News Politics World News Climate Crisis Housing Cost of Living Road Safety Courts Ukraine Gaza Newsletters FactCheck Temperature Check Inside the Newsroom Podcasts The Explainer A deep dive into one big news story Sign in to have your say Or create a free account to join the discussion Advertisement Read Next More Stories ![](\\" Simon Harris plays down election talk (as he canvasses with Fine Gael candidates in Dublin) ![](\\" Teachers slam government for €9m spend on locking phones during school ![](\\" As it happened: How today\'s big Budget 2025 giveaway played out FACTCHECK # Debunked: A claim which describes \'major concerns\' about the AstraZeneca vaccine is misleading The claim has been shared on Facebook. 1.00pm, 10 Jul 2021 33.5k A CLAIM THAT people who received the AstraZeneca vaccine are now more likely to suffer a stroke has been shared over a hundred times on social media. The claim relies on an article published by The Liberal in May, which claimed that “new evidence” had emerged that suggested that getting the jab meant that people “might now be at risk of suffering a stroke”. The article described how three people had suffered strokes within 30 days of having the AstraZeneca vaccine, one of whom subsequently died. It states that there is now “major concern” about the jab and claimed that Ireland continues to administer the vaccine “without any apparent concerns or misgivings”. However, health concerns about the AstraZeneca vaccine are minuscule and Ireland has taken a number of precautions about administering it to people who may suffer adverse effects from it. Although there were reports of people who suffered strokes around the time The Liberal’s piece was published, the article does not refer to any scientific evidence which suggests that a person is at a higher risk of stroke after taking the vaccine. This is not to say there is no risk: links between strokes and the jab were confirmed by the British Heart Foundation (BHF), among others. However, the foundation says there have been “a very small number of reports” of adults under the age of 45 who suffered a stroke within a month of having the AstraZeneca vaccine. Crucially, the BHF notes that it is not known whether these strokes were caused by the vaccine. “Even if a link between the AstraZeneca vaccine and stroke is proven, it’s important to remember that the chance of having a stroke due to the vaccine is extremely low, and that stroke is more common in people who get Covid-19,” the foundation says. In a Sky News article detailing the cases of the three people who suffered strokes, a team from University College London (UCL) Hospital’s NHS Foundation Trust stressed the risks of suffering a stroke due to the AstraZeneca vaccine are small, and the the risk of someone having a stroke is actually greater if they contract Covid-19. Medicines and Healthcare products Regulatory Agency chief executive Dr June Raine told Sky: “No effective medicine or vaccine is without risk.” “Our advice remains that the benefits of the vaccine outweigh the risks in the majority of people.” Irish experts issued similar guidance earlier this year, when concerns about the risk of stroke from AstraZeneca first arose. On 19 March, Professor Joe Harbison, who is clinical lead of the Irish National Audit of Stroke, told RTÉ’s Morning Ireland how a much higher percentage of people who caught Covid-19 developed stroke symptoms than those who were given AstraZeneca. He explained that one to two per cent of people hospitalised with Covid-19 during the first wave of the pandemic in Ireland suffered a stroke, compared with a “less than a one in a million chance” of a person developing a problem due to the vaccine. Risk of clotting This is not to say there weren’t any concerns about AstraZeneca, or that Ireland has administered the vaccine “without misgivings”. Advertisement In March, Ireland joined a number of EU countries by temporarily suspending the use of the vaccine, amid concerns about a small number of blood-clotting incidents among those who had received the jab. In total, 86 cases of potential blood clotting were detected after around 25 million people across Europe had received the vaccine. But in April, the European Medicines Agency (EMA) conducted a review of the jab and concluded that the benefits of the vaccine outweighed the risks, and that the unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine. This led to Ireland suspending the use of the vaccine for anyone under the age of 60 following a recommendation from the National immunisation Advisory Committee (NIAC). NIAC then recommended that AstraZeneca should not be given to people under 50 in Ireland. This subsequently reduced to 40 in May. At the time, NIAC chair Professor Karina Butler outlined that someone aged 60-64 was 85 times more likely to die of Covid-19 than to have any clotting event from the vaccine. People aged 55-59 were 48 times more likely to die of Covid-19 than get a blood clot, while among the 20-30 age group, the risk of dying from Covid was twice as likely, than to develop any clotting event related to the AstraZeneca vaccine. However, NIAC’s advice remained to limit the use of AstraZeneca to older sections of the population, because other vaccines which did not present the same (minimal) risk to younger people were available. This advice has changed in recent weeks, following the emergence of the Delta variant, now the most dominant in Ireland. NIAC’s advice now allow people under 40 be given the jab, in order to ensure that the highest number of people are protected as soon as possible. Administering the vaccine to the younger age cohort still carries a small risk, but the risks involved in contracting the Delta variant – and developing severe illness or long Covid – are much greater. Over 750 pharmacies began vaccinating the 18-34 age group on Monday, while patients can also register to have the AstraZeneca vaccine at a vaccination centre from 12 July. But this is strictly on an opt-in basis: those who are still concerned about the AstraZeneca vaccine can avail of the Johnson & Johnson vaccine or an mRNA vaccine from Pfizer or Moderna instead. And even despite these concerns, we still know that all Covid-19 vaccines – including AstraZeneca – have been overwhelmingly safe to use. All of the vaccines authorised by the European Medicines Agency have reduced severe infection, hospitalisation and death in Covid-19 patients who have received them. More than half of the adult population of Ireland – comprising millions of people – have now been fully vaccinated against Covid-19, with hundreds of thousands more having received a first dose. No link between a Covid-19 vaccine and any case of severe illness or death has been established in any individual in Ireland. It is misleading to say there are “major concerns” about the AstraZeneca vaccine or any other jab available here. Contains reporting from previous FactChecks by Stephen McDermott. The Journal’s FactCheck is a signatory to the International Fact-Checking Network’s Code of Principles. You can read it here. For information on how FactCheck works, what the verdicts mean, and how you can take part, check out our Reader’s Guide here. You can read about the team of editors and reporters who work on the factchecks here. Have you gotten a message on WhatsApp or Facebook or Twitter about coronavirus or another topic that you’re not sure about and want us to check it out? Message or mail us and we’ll look into debunking it. WhatsApp: 085 221 4696 or Email: answers@thejournal.ie. Readers like you are keeping these stories free for everyone... It is vital that we surface facts from noise. Articles like this one brings you clarity, transparency and balance so you can make well-informed decisions. We set up FactCheck in 2016 to proactively expose false or misleading information, but to continue to deliver on this mission we need your support. Over 5,000 readers like you support us. If you can, please consider setting up a monthly payment or making a once-off donation to keep news free to everyone. Learn More Support The Journal Sign Up FactCheck The Journal\'s monthly FactCheck newsletter keeps you in the loop about what misinformation trends Ireland is experiencing - and how we\'re fighting back. Sign up here Sign Up Email sign up confirmed ![](\\" Author Jane Moore jane@thejournal.ie @janemoore__ Send Tip or Correction View all articles Read Next More Stories ![](\\" Simon Harris plays down election talk (as he canvasses with Fine Gael candidates in Dublin) ![](\\" Teachers slam government for €9m spend on locking phones during school ![](\\" As it happened: How today\'s big Budget 2025 giveaway played out Related Tags AstraZeneca blood clots covid19 facts debunked FactCheck Vaccines Embed this post To embed this post, copy the code below on your site 600px wide <iframe width=\"600\" height=\"460\" frameborder=\"0\" style=\"border:0px;\" src=\" covid-19-stroke-risk-5487059-Jul2021/?embedpost=5487059&width=600&height=460\" ></iframe> 400px wide <iframe width=\"600\" height=\"460\" frameborder=\"0\" style=\"border:0px;\" src=\" covid-19-stroke-risk-5487059-Jul2021/?embedpost=5487059&width=400&height=460\" ></iframe> 300px wide <iframe width=\"600\" height=\"460\" frameborder=\"0\" style=\"border:0px;\" src=\" covid-19-stroke-risk-5487059-Jul2021/?embedpost=5487059&width=300&height=460\" ></iframe> Email “Debunked: A claim which describes \'major concerns\' about the AstraZeneca vaccine is misleading”. Your Email Recipient\'s Email Submit ![\\"One](\\"//b0.thejournal.ie/desktop/i/loading.gif\\") Feedback on “Debunked: A claim which describes \'major concerns\' about the AstraZeneca vaccine is misleading”. Your Feedback Your Email (optional) Submit ![\\"One](\\"\\") Report a Comment Please select the reason for reporting this comment. Please select your reason for reporting... It contains offensive language, is hateful or incites violence It contains a libellous/defamatory statement Some other reason... Please give full details of the problem with the comment... Submit ![\\"One](\\"//b0.thejournal.ie/desktop/i/loading.gif\\") ![\\"JournalTv\\"](\\"/tv/poster/news-in-60-seconds\\"/) News in 60 seconds more from us Sections * Voices * FactCheck * Investigates * Daft.ie Property Magazine * Money Diaries * The Journal TV Journal Media * About us * Careers * Contact * Advertise With Us * About FactCheck Our Network * The 42 * FactCheck Knowledge Bank Terms & Legal Notices * Terms of Use * Cookies & Privacy * Advertising * Comments * Copyright * Competition more from us Sections * TV Listings * Quizzes * Live Blogs * GAA Fixtures Journal Media * About us * Careers * Contact * Advertise With Us Our Network * The Journal * FactCheck Knowledge Bank Terms & Legal Notices * Terms of Use * Cookies & Privacy * Advertising * Comments * Copyright * Competition © 2024 Journal Media Ltd * Terms of Use * Cookies & Privacy * Advertising * Comments * Copyright * Competition Switch to Desktop Switch to Mobile The Journal supports the work of the Press Council of Ireland and the Office of the Press Ombudsman, and our staff operate within the Code of Practice. You can obtain a copy of the Code, or contact the Council, at PH: (01) 6489130, Lo-Call 1800 208 080 or email: mailto:info@presscouncil.ie Report an error, omission or problem: Message: Your Email (optional) Submit ![\\"One](\\"//b0.thejournal.ie/desktop/i/loading.gif\\") Create Email Alert Create an email alert based on the current article Email Address One email every morning As soon as new articles come online Submit ![\\"One](\\"//b0.thejournal.ie/desktop/i/loading.gif\\") ![](\\"/i.php?i=5487059&r=172787739222260&key=article_5487059&interaction=view\\"/) ## Your Cookies. Your Choice. Cookies help provide our news service while also enabling the advertising needed to fund this work. We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free). We and our 107 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting \"I Accept\" enables tracking technologies to support the purposes shown under \"we and our partners process data to provide,\" whereas selecting \"Reject All\" or withdrawing your consent will disable them. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the [\"privacy preferences\"] link on the bottom of the webpage [or the floating icon on the bottom-left of the webpage, if applicable]. Your choices will have effect within our Website. For more details, refer to our Privacy Policy. ### We and our vendors process data for the following purposes: Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development. List of Vendors Accept All Cookies Settings ![\\"The](\\" ## Cookies Preference Centre We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework. Allow All ### Manage Consent Preferences #### Necessary Cookies Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. Cookies Details‎ #### Targeting Cookies Targeting Cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Cookies Details‎ #### Functional Cookies Functional Cookies These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly. Cookies Details‎ #### Performance Cookies Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance. Cookies Details‎ #### Store and/or access information on a device 72 partners can use this purpose Store and/or access information on a device Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here. List of IAB Vendors‎ | View Illustrations #### Personalised advertising and content, advertising and content measurement, audience research and services development 97 partners can use this purpose Personalised advertising and content, advertising and content measurement, audience research and services development * ##### Use limited data to select advertising 74 partners can use this purpose Switch Label Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you). View Illustrations * ##### Create profiles for personalised advertising 49 partners can use this purpose Switch Label Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities. View Illustrations * ##### Use profiles to select personalised advertising 48 partners can use this purpose Switch Label Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects. View Illustrations * ##### Create profiles to personalise content 24 partners can use this purpose Switch Label Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests. View Illustrations * ##### Use profiles to select personalised content 20 partners can use this purpose Switch Label Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests. View Illustrations * ##### Measure advertising performance 91 partners can use this purpose Switch Label Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns. View Illustrations * ##### Measure content performance 47 partners can use this purpose Switch Label Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non- advertising) content that is shown to you. View Illustrations * ##### Understand audiences through statistics or combinations of data from different sources 53 partners can use this purpose Switch Label Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents). View Illustrations * ##### Develop and improve services 60 partners can use this purpose Switch Label Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers. View Illustrations * ##### Use limited data to select content 28 partners can use this purpose Switch Label Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you). View Illustrations List of IAB Vendors‎ #### Use precise geolocation data 33 partners can use this special feature Use precise geolocation data With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice. List of IAB Vendors‎ #### Ensure security, prevent and detect fraud, and fix errors 59 partners can use this special purpose Always Active Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them. List of IAB Vendors‎ | View Illustrations #### Deliver and present advertising and content 67 partners can use this special purpose Always Active Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device. List of IAB Vendors‎ | View Illustrations #### Match and combine data from other data sources 49 partners can use this feature Always Active Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice. List of IAB Vendors‎ #### Link different devices 36 partners can use this feature Always Active In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices). List of IAB Vendors‎ #### Identify devices based on information transmitted automatically 61 partners can use this feature Always Active Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice. List of IAB Vendors‎ #### Save and communicate privacy choices 38 partners can use this special purpose Always Active The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices. List of IAB Vendors‎ | View Illustrations Back Button ### Cookie List Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Reject All Confirm My Choices ![\\"Powered](\\"
The factchecking of vaccines and COVID19 stroke risk on July 2021